Trial record 1 of 1 for: nct01094691
Previous Study | Return to List | Next Study
Haufen Diagnostic Biomarkers of BK Renal Disease
This study is enrolling participants by invitation only.
University of North Carolina, Chapel Hill
Astellas Pharma US, Inc.
Information provided by (Responsible Party):
Volker Nickeleit, MD, University of North Carolina, Chapel Hill
First received: March 25, 2010
Last updated: April 9, 2014
Last verified: April 2014
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study is enrolling participants by invitation only.|
|Estimated Study Completion Date:||June 2016|
|Estimated Primary Completion Date:||December 2015 (Final data collection date for primary outcome measure)|